Metformin ameliorates diet-induced hepatic steatosis and inflammation without altering adipose phenotype (37.1)

Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis and inflammation, and is closely associated with obesity. We examined the effects of metformin on hepatic steatosis a...